Oral Oncology
Volume 46, Issue 7 , Pages 497-503, July 2010

A meta-analysis of alcohol drinking and oral and pharyngeal cancers. Part 1: Overall results and dose-risk relation

  • Irene Tramacere

      Affiliations

    • Istituto di Ricerche Farmacologiche “Mario Negri”, Milano, Italy
  • ,
  • Eva Negri

      Affiliations

    • Istituto di Ricerche Farmacologiche “Mario Negri”, Milano, Italy
  • ,
  • Vincenzo Bagnardi

      Affiliations

    • Department of Statistics, University of Milano-Bicocca, Milano, Italy
    • Division of Epidemiology and Biostatistics, European Institute of Oncology, Milano, Italy
  • ,
  • Werner Garavello

      Affiliations

    • Istituto di Ricerche Farmacologiche “Mario Negri”, Milano, Italy
    • Clinica Otorinolaringoiatrica, DNTB, Università degli Studi di Milano-Bicocca, Milano, Italy
  • ,
  • Matteo Rota

      Affiliations

    • Department of Statistics, University of Milano-Bicocca, Milano, Italy
    • Department of Clinical Medicine and Prevention, Centre of Biostatistics for Clinical Epidemiology, University of Milan-Bicocca, Monza, Italy
  • ,
  • Lorenza Scotti

      Affiliations

    • Department of Statistics, University of Milano-Bicocca, Milano, Italy
  • ,
  • Farhad Islami

      Affiliations

    • International Agency for Research on Cancer, Lyon, France
    • Digestive Disease Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
  • ,
  • Giovanni Corrao

      Affiliations

    • Department of Statistics, University of Milano-Bicocca, Milano, Italy
  • ,
  • Paolo Boffetta

      Affiliations

    • International Prevention Research Institute, Lyon, France
    • The Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY, USA
  • ,
  • Carlo La Vecchia

      Affiliations

    • Istituto di Ricerche Farmacologiche “Mario Negri”, Milano, Italy
    • Section of Medical Statistics, Department of Occupational Health, Università degli Studi di Milano, Milano, Italy
    • Corresponding Author InformationCorresponding author at: Istituto di Ricerche Farmacologiche “Mario Negri”, Via Giuseppe La Masa 19, 20156 Milan, Italy. Tel.: +39 02 39 01 4527; fax: +39 02 33 200 231.

Received 22 February 2010; received in revised form 30 March 2010; accepted 30 March 2010. published online 05 May 2010.

Summary 

Alcohol consumption, together with tobacco, is the best recognised risk factor for oral and pharyngeal cancers (OPC), but several important aspects of this association need to be further explored. In order to provide up to date and more precise quantification of the association between alcohol drinking and OPC risk, we conducted a meta-analysis of available data. We performed a PubMed search of articles published up to September 2009, and we identified 43 case-control and two cohort studies presenting results for at least three categories of alcohol drinking, including a total of 17,085 OPC cases. We derived meta-analytic summary estimates using random-effects models, and taking into account correlation between estimates. We also performed a dose-risk analysis using non-linear random-effects meta-regression models. The pooled relative risk (RR) was 1.21 (95% confidence interval, CI, 1.10–1.33) for⩽1 drink per day, and rose to 5.24 (95% CI, 4.36–6.30) for heavy alcohol drinking (⩾4 drinks per day). The dose-risk analysis resulted in RR of 1.29 for 10g ethanol/day, 3.24 for 50g ethanol/day, 8.61 for 100g ethanol/day, and 13.02 for 125g ethanol/day. This meta-analysis provides more precise evidence of a gross excess of OPC risk for heavy alcohol drinkers. It also indicates an increased risk for moderate doses, i.e., ⩽1 drink or 10g ethanol/day.

Keywords: Alcohol drinking, Dose-risk relation, Meta-analysis, Oral and pharyngeal caner, Systematic review

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1368-8375(10)00136-3

doi:10.1016/j.oraloncology.2010.03.024

Oral Oncology
Volume 46, Issue 7 , Pages 497-503, July 2010